Skip to search formSkip to main contentSkip to account menu

A 56620

Known as: A-56620 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sarafloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis
A rabbit model for Staphylococcus aureus osteomyelitis was used to compare the results of treatment with A-56619 and A-56620, two… 
Highly Cited
1987
Highly Cited
1987
4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro
Most antibacterial agents do not affect human lymphocyte function, but a few are inhibitory. In contrast, a pronounced increase… 
Highly Cited
1986
Highly Cited
1986
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
The in vitro antibacterial potencies of A-56619 and A-56620, two new aryl-fluoroquinolones, were compared with the potency of… 
Highly Cited
1986
Highly Cited
1986
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus
Seven quinolone antibiotics were tested against 115 isolates of methicillin-resistant Staphylococcus aureus. The MICs for 90% of… 
1986
1986
Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620
The in vitro activity of difloxacin (A-56619) and A-56620, two new aryl-difluoroquinolones, was decreased by magnesium at 9 mM… 
1986
1986
In vitro evaluation of A-56619 and A-56620, two new quinolones
The in vitro activities of two new aryl-fluoroquinolones (A-56619 and A-56620) were compared with those of ciprofloxacin… 
1986
1986
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones
A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered… 
Highly Cited
1986
Highly Cited
1986
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
The in-vitro antibacterial activity of nalidixic acid and the 4-quinolones, ciprofloxacin, norfloxacin, enoxacin, ofloxacin… 
1986
1986
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens
Management of sexually transmitted diseases is facilitated by having antimicrobial agents with activity against all of the major… 
Highly Cited
1985
Highly Cited
1985
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620
The in vitro activities of two new quinolone antimicrobial agents, A-56619 and A-56620, were compared with those of norfloxacin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)